Hallmarks and Biomarkers of Skin Senescence: An Updated Review of Skin Senotherapeutics

Aging is a complex process characterized by an ongoing decline in physiological functions, leading to degenerative diseases and an increased probability of death. Cellular senescence has been typically considered as an anti-proliferative process; however, the chronic accumulation of senescent cells...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Darya Bulbiankova (Автор), Rocío Díaz-Puertas (Автор), Francisco Javier Álvarez-Martínez (Автор), María Herranz-López (Автор), Enrique Barrajón-Catalán (Автор), Vicente Micol (Автор)
Формат:
Опубликовано: MDPI AG, 2023-02-01T00:00:00Z.
Предметы:
Online-ссылка:Connect to this object online.
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a52b4f20f0d94a3f9c236df1b966a439
042 |a dc 
100 1 0 |a Darya Bulbiankova  |e author 
700 1 0 |a Rocío Díaz-Puertas  |e author 
700 1 0 |a Francisco Javier Álvarez-Martínez  |e author 
700 1 0 |a María Herranz-López  |e author 
700 1 0 |a Enrique Barrajón-Catalán  |e author 
700 1 0 |a Vicente Micol  |e author 
245 0 0 |a Hallmarks and Biomarkers of Skin Senescence: An Updated Review of Skin Senotherapeutics 
260 |b MDPI AG,   |c 2023-02-01T00:00:00Z. 
500 |a 10.3390/antiox12020444 
500 |a 2076-3921 
520 |a Aging is a complex process characterized by an ongoing decline in physiological functions, leading to degenerative diseases and an increased probability of death. Cellular senescence has been typically considered as an anti-proliferative process; however, the chronic accumulation of senescent cells contributes to tissue dysfunction and aging. In this review, we discuss some of the most important hallmarks and biomarkers of cellular senescence with a special focus on skin biomarkers, reactive oxygen species (ROS), and senotherapeutic strategies to eliminate or prevent senescence. Although most of them are not exclusive to senescence, the expression of the senescence-associated beta-galactosidase (SA-β-gal) enzyme seems to be the most reliable biomarker for distinguishing senescent cells from those arrested in the cell cycle. The presence of a stable DNA damage response (DDR) and the accumulation of senescence-associated secretory phenotype (SASP) mediators and ROS are the most representative hallmarks for senescence. Senotherapeutics based on natural compounds such as quercetin, naringenin, and apigenin have shown promising results regarding SASP reduction. These compounds seem to prevent the accumulation of senescent cells, most likely through the inhibition of pro-survival signaling pathways. Although studies are still required to verify their short- and long-term effects, these therapies may be an effective strategy for skin aging. 
546 |a EN 
690 |a aging 
690 |a biomarker 
690 |a ROS 
690 |a SASP 
690 |a senescence 
690 |a senotherapy 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antioxidants, Vol 12, Iss 2, p 444 (2023) 
787 0 |n https://www.mdpi.com/2076-3921/12/2/444 
787 0 |n https://doaj.org/toc/2076-3921 
856 4 1 |u https://doaj.org/article/a52b4f20f0d94a3f9c236df1b966a439  |z Connect to this object online.